Zusammenfassung
Wiederholungseingriffe an den Nebennieren können bei ipsilateralen benigen oder malignen Rezidiven nach subtotaler oder totaler Adrenalektomie, aber auch bei kontralateralen Rezidiverkrankungen nach unilateraler Adrenalektomie erforderlich werden. Die chirurgische Behandlung von Lokalrezidiven maligner Nebennierentumoren erreicht zumindest bei adrenokortikalen Karzinomen bei kompletter und unter Umständen auch multiviszeraler Resektion die gleichen Ergebnisse wie die operative Therapie bei Erstmanifestation (Fünfjahresüberlebensraten zwischen 40–60%). Palliative Operationen sollten nur individuell zur Kontrolle endokriner Symptome erwogen werden, da eine Verlängerung der Überlebenszeit im Vergleich zur konservativen Therapie nicht eindeutig belegt ist. Der Stellenwert der endoskopischen Techniken bei großen (>5 cm) und somit potenziell malignen Nebennierentumoren muss in weiteren Studien untersucht werden, bevor eine abschließende Einschätzung möglich ist. Nach subtotaler Adrenalektomie hängt das Rezidivrisiko von der Grunderkrankung, Größe und Lokalisation des adrenalen Restgewebes, Dauer der Nachbeobachtung sowie, im Falle familiärer Phäochromozytome, von der zugrunde liegenden Mutation (Genotyp) ab.
Abstract
Repeat adrenalectomy may be required due to ipsilateral recurrence of benign or malignant adrenal tumors after previous total or subtotal adrenalectomy. Even for multivisceral resection in patients with adrenocortical carcinoma, complete resection of local recurrent tumor offers results similar to those of primary resection (5-year survival 40–60%). In contrast, since no benefit on long-term survival has been shown so far by tumor debulking, palliative tumor resection should only be performed individually for control of severe endocrine symptoms. The effect of endoscopic adrenalectomy in patients with large tumors (>5 cm) or suspected malignancy has still not been well examined. Further studies are required. In any case, during open or endoscopic approach, tumor spillage must be avoided to prevent local tumor cell implantation. Following subtotal adrenalectomy, the risk of ipsilateral recurrence correlates with disease, follow-up, localization, size of the adrenal remnant, and, in case of familial pheochromocytoma, probably with genotype.
Literatur
Allolio B, Hahner S, Weismann D, Fassnacht M (2004) Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60:273–287
Albanese CT, Wiener ES (1993) Routine total bilateral adrenalectomy is not warranted in childhood familial pheochromocytoma. J Pediatr Surg 28:1248–1251
Al-Sobhi S, Peschel R, Zihak C, Bartsch G, Neumann H, Janetschek G (2002) Laparoscopic partial adrenalectomy for recurrent pheochromocytoma after open partial adrenalectomy in von Hippel-Lindau disease. J Endourol 16:171–174
Baghai M, Thompson GB, Young WF Jr, Grant CS, Michels VV, van Heerden JA (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682–688
Bellantone R, Ferrante A, Boscherini M et al. (1997) Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 122:1212–1218
Birnbaum J, Giuliano A, Van Herle AJ (1989) Partial adrenalectomy for pheochromocytoma with maintenance of adrenocortical function. J Clin Endocrinol Metab 69:1078–1081
Brauckhoff M, Gimm O, Brauckhoff K, Dralle H (2004) Repeat adrenocortical-sparing adrenalectomy for recurrent hereditary pheochromocytoma. Surg Today 34:251–255
Brauckhoff M, Gimm O, Thanh PN et al. (2003) Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy. Surgery 134:1020–1027
Brennan MF, Keiser HR (1982) Persistent and recurrent pheochromocytomas: the role of surgery. World J Surg 6:397–402
Chong GC, ReMine WH, Sheps SG (1974) Recurrent pheochromocytoma from direct peritoneal implantation. Report of two patients with 22-year survival periods. Minn Med 57:951–952
Dackiw AP, Lee JE, Gagel RF, Evans DB (2001) Adrenal cortical carcinoma. World J Surg 25:914–926
Deckers S, Derdelincks L, Col V, Hamels J, Maiter D (1999) Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing hyperaldosteronims. Horm Res 52:97–100
deGraaf JS, Lips CJM, Rütter JE, van Vroonhoven TJMV (1999) Subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2A. Eur J Surg 165:535–538
Edstrom E, Grondal S, Norstrom F, Palmer M, Svensson KA, Widell H, Hamberger B (1999) Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa. Eur J Surg 165:431–435
Fendrich V, Ramaswamy A, Nies C (2003) Hyperaldosteronism persisting after subtotal adrenalectomy. Chirurg 74:473–477
Hamberger B, Telenius-Berg M, Cedermark B, Grondal S, Hansson BG, Werner S (1987) Subtotal adrenalectomy in multiple endocrine neoplasia type 2. Henry Ford Hosp Med J 35:127-128
Harrison TS, Freier DT, Cohen EL (1974) Proceedings: Recurrent pheochromocytoma. Arch Surg 108:450–454
Heniford BT, Iannitti DA, Hale J, Gagner M (1997) The role of intraoperative ultrasonography during laparoscopic adrenalectomy. Surgery 122:1068–1073
Henry JF, Sebag F, Iacobone M, Mirallie E (2002) Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg 26:1043–1047
Icard P, Louvel A, Chapuis Y (1992) Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 16:753–758
Ilias I, Yu J, Carrasquillo JA (2003) Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88:4083–4087
Inabnet WB, Caragliano P, Pertsemlidis D (2000) Pheochromocytoma: inherited associations, bilaterality, and cortex preservation. Surgery 128:1007–1112
Irvin GL 3rd, Fishman LM, Sher JA (1983) Familial pheochromocytoma. Surgery 94:938–940
Ito Y, Fujimoto Y, Obara T, Kodama T (1990) Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma. World J Surg 14:330–334
Janetschek G, Finkenstedt G, Gasser R, Waibel UG, Peschel R, Bartsch G, Neumann HP (1998) Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol 160:330–334
John H, Ziegler WH, Hauri D, Jaeger P (1999) Pheochromocytomas: can malignant potential be predicted. Urology 53:679–683
Kageyama Y, Ishizaka K, Iwashina M, Sasano H, Kihara K (2002) A case of ACTH-independent macronodular adrenal hyperplasia successfully treated by subtotal resection of the adrenal glands: four-year follow-up. Endocr J 49:227–229
Kaltsas G, Rockall A, Papadogias D, Reznek R, Grossman AB (2004) Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 151:15–27
Kendrick ML, Lloyd R, Erickson L (2001) Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136:543–549
Kendrick ML, Curlee K, Lloyd R (2002) Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes. Surgery 132:1008–1011
Klempa I, Menzel J, Baca I (1989) Subtotal adrenalectomy versus autotransplantation of the adrenal cortex--an alternative procedure in bilateral adrenalectomy in MEN II? Chirurg 60:266–271
Koch CA, Pacak K, Chrousos GP (2002) Genetics of endocrine disease: The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 87:5367–5384
Kopf D, Bockisch A, Steinert H (1997) Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma. Clin Endocrinol (Oxf) 46:39–44
Lacroix A, Ndiaye N, Tremblay J, Hamet P (2001) Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev 22:75–110
Lee JE, Berger DH, El-Naggar AK (1995) Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery 118:1090–1098
Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120:1064–1070
Lehnert H, Mundschenk J, Hahn K (2004) Malignant pheochromocytoma. Front Horm Res 31:155–162
Li LM, Fitzgerald PA, Price DC, Norton JA (2001) Iatrogenic pheochromocytomatosis: a previously unreported result of laparsocopic adrenalectomy. Surgery 130:1072–1077
Modigliani E, Vasen HM, Raue K et al. (1995) Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. J Intern Med 238:363–367
Mugiya S, Suzuki K, Saisu K, Fujita K (1999) Unilateral laparoscopic adrenalectomy followed by contralateral retroperitoneoscopic partial adrenalectomy in a patient with multiple endocrine neoplasia type 2a syndrome. J Endourol 13:99–104
Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ (2000) Long-term results of total adrenalectomy for Cushing’s disease. World J Surg 24:108–113
Nambirajan T, Bagheri F, Abdelmaksoud A, Leeb K, Neumann H, Graubner UB, Janetschek G (2004) Laparoscopic partial adrenalectomy for recurrent pheochromocytoma in a boy with Von Hippel-Lindau disease. J Laparoendosc Adv Surg Tech A 14:234–235
Neumann HPH, Bender BU, Reincke M, Eggstein S, Laubenberger J, Kirste G (1999) Adrenal-sparing surgery for pheochromocytoma. Br J Surg 86:94–97
Pommier RF, Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma. Surgery 112:963–970
Porpiglia F, Destefanis P, Bovio S et al. (2002) Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA. Horm Res 57:197–199
Radmayr C, Neumann H, Bartsch G, Elsner R, Janetschek G (2000) Laparoscopic partial adrenalectomy for bilateral pheochromocytomas in a boy with von Hippel-Lindau disease. Eur Urol 38:344–348
Rainis T, Ben-Haim S, Dickstein G (2000) False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma. J Clin Endocrinol Metab 85:5–7
Rote AR, Flint LD, Ellis FH Jr (1977) Intracaval recurrence of pheochromocytoma extending into right atrium. Surgical management using extracorporeal circulation. N Engl J Med 296:1269–1271
Rotker J, Oberpennig F, Scheld HH, Hertle L, Knichwitz G, Hammel D (1996) Pheochromocytomas with extension into central vascular structures. Ann Thorac Surg 61:222–224
Sackett WR, Bambach CP (2003) Bilateral subtotal laparoscopic adrenalectomy for phaeochromocytoma. ANZ J Surg 73:664–666
Safford SD, Coleman RE, Gockerman JP (2003) Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery 134:956–962
Schmoll HJ, Dralle H (1999) Nebennierenkarzinom. In: Schmoll HJ, Höffken K, Possinger K (Hrsg) Kompendium Internistische Onkologie. Springer. 1230–1251
Schulick RD, Brennan MF (1999) Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 6:719–726
Tenenbaum F, Groussin L, Foehrenbach H (2004) 18F-fluordeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumors? Preliminary results in 13 consecutive patients. Eur J Endocrinol 150:789–792
Ushiyama T, Suzuki K, Kageyama S, Fujita K, Oki Y, Yoshimi T (1997) A case of Cushing‘s syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy. J Urol 157:2239
van Heerden JA, Sizemore GW, Carney JA, Grant CS, ReMine WH, Sheps SG (1984) Surgical Management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg 8:612–621
van Heerden JA, Roland CF, Carney JA, Sheps SG, Grant CS (1990) Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg 14:325–329
Walther MM, Keiser HR, Choyke PL, Rayford W, Lyne JC, Linehan WM (1999) Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol 161:395–398
Walther MM, Herring J, Choyke PL, Linehan WM (2000) Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 164:14–17
Walz MK, Peitgen K, Neumann HP, Janssen OE, Philipp T, Mann K (2002) Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg 26:1005–1012
Walz MK, Peitgen K, Saller B et al. (1998) Subtotal adrenalectomy by the posterior retroperitoneoscopic approach. World J Surg 22:621–626
Walz MK, Peitgen K et al. (2004) Partial versus Total Adrenalectomy by the Posterior Retroperitoneoscopic Approach: Early and Long-term Results of 325 Consecutive Procedures in Primary Adrenal Neoplasias. World J Surg 28:1323–1329
Warinner SA, Zimmermann D, Thrompson GB, Grant CS (2000) Study of three patients with congenital adrenal hyperplasia treated by bilateral adrenalectomy. World J Surg 24:1347–1352
Welbourn RB (1985) Survival and causes of death after adrenalectomy for Cushing’s disease. Surgery 97:16–20
Yip L, Lee JE, Shapiro SE, Waguespack SG et al. (2004) Surgical Management of hereditary pheochromocytoma. J Am Coll Surg 198:525–535
Yoshida S. Hatori M, Noshiro T, Kimura N, Kokubun S (1999) Twenty-six-year‘s survival with multiple bone metasasis of malignant pheochromocytoma. Arch Orthop Trauma Surg 121:589–600
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brauckhoff, M., Dralle, H. Wiederholungseingriffe an den Nebennieren. Chirurg 76, 227–237 (2005). https://doi.org/10.1007/s00104-005-1010-5
Issue Date:
DOI: https://doi.org/10.1007/s00104-005-1010-5
Schlüsselwörter
- Rezidiv
- Nebennierenkarzinom
- Mitotane
- Malignes Phäochromozytom
- Radioligandentherapie
- Rezidivadrenalektomie
- Subtotale Adrenalektomie